PMID: 8940755Sep 1, 1996Paper

Planning and delivering high doses to targets surrounding the spinal cord at the lower neck and upper mediastinal levels: static beam-segmentation technique executed with a multileaf collimator

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
W De NeveJ Schelfhout

Abstract

It remains a technical challenge to limit the dose to the spinal cord below tolerance if, in head and neck or thyroid cancer, the planning target volume reaches to a level below the shoulders. In order to avoid these dose limitations, we developed a standard plan involving Beam Intensity Modulation (BIM) executed by a static technique of beam segmentation. In this standard plan, many machine parameters (gantry angles, couch position, relative beam and segment weights) as well as the beam segmentation rules were identical for all patients. The standard plan involved: the use of static beams with a single isocenter; BIM by field segmentation executable with a standard Philips multileaf collimator; virtual simulation and dose computation on a general 3D-planning system (Sherouse's GRATIS); heuristic computation of segment intensities and optimization (improving the dose distribution and reducing the execution time) by human intelligence. The standard plan used 20 segments spread over 8 gantry angles plus 2 non-segmented wedged beams (2 gantry angles). The dose that could be achieved at the lowest target voxel, without exceeding tolerance of the spinal cord (50 Gy at highest voxel) was 70-80 Gy. The in-target 3D dose-inhomogeneity ...Continue Reading

References

Aug 1, 1991·International Journal of Radiation Oncology, Biology, Physics·S L SailerJ E Tepper
Oct 1, 1990·Physics in Medicine and Biology·T BortfeldW Schlegel
Jun 1, 1988·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·A Brahme
Oct 1, 1982·Physics in Medicine and Biology·A BrahmeI Lax
Jun 15, 1995·International Journal of Radiation Oncology, Biology, Physics·J W SohnS Pohar
Nov 1, 1993·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S SöderströmA Brahme

❮ Previous
Next ❯

Citations

May 12, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Rafael ArránsFrancisco Sánchez-Doblado
Aug 6, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K BratengeierM Flentje
Dec 4, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·L CozziA Bolsi
Dec 4, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F ClausW De Neve
Jul 7, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W De NeveC De Waeter
Feb 9, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K De VlamynckW De Neve
Aug 5, 2000·International Journal of Radiation Oncology, Biology, Physics·A ZurloA Loasses
Sep 7, 2000·International Journal of Radiation Oncology, Biology, Physics·M D PosnerL J Verhey
Nov 10, 2000·International Journal of Radiation Oncology, Biology, Physics·A PirzkallJ Debus
Dec 21, 2000·International Journal of Radiation Oncology, Biology, Physics·A PirzkallJ Debus
May 31, 2001·International Journal of Radiation Oncology, Biology, Physics·C MartensC De Wagter
Sep 25, 2001·International Journal of Radiation Oncology, Biology, Physics·F ClausW De Neve
Nov 9, 2001·International Journal of Radiation Oncology, Biology, Physics·W De GersemW De Neve
Nov 13, 2001·International Journal of Radiation Oncology, Biology, Physics·UNKNOWN Intensity Modulated Radiation Therapy Collaborative Working Group
Jan 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Andrea PirzkallM Wannenmacher
Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Dietmar GeorgRichard Pötter
Oct 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Wim DuthoyWilfried De Neve
Aug 1, 1997·International Journal of Radiation Oncology, Biology, Physics·D VerellenG Storme
Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·M J BrugmansB J Mijnheer
Dec 29, 1999·International Journal of Radiation Oncology, Biology, Physics·A FogliataJ Bernier
Dec 29, 1999·International Journal of Radiation Oncology, Biology, Physics·M A Keller-ReichenbecherW Schlegel
Jul 11, 2001·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·U Oelfke, T Bortfeld
May 22, 2002·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Moyed M MiftenLawrence B Marks
May 30, 2003·Medical Physics·J E BayouthS M Morrill
May 23, 2012·International Journal of Telemedicine and Applications·S Zimeras, L G Gortzis
Feb 25, 2009·Medical Physics·Hiroshi Oguchi, Yasunori Obata
Jan 30, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Y De DeeneE Achten
Jun 19, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C De WagterW J De Neve
Jan 13, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S DeryckeW De Neve
Feb 22, 2016·Artificial Intelligence in Medicine·Sanja PetrovicRupa Jagannathan
May 26, 2012·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·S A Syam KumarNagarajan Vivekanandan
Apr 24, 2012·Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)·M Skórska, T Piotrowski
Aug 15, 2009·Zeitschrift für medizinische Physik·Klaus BratengeierMichael Flentje
Aug 21, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Klaus BratengeierMichael Flentje
Mar 31, 2004·International Journal of Radiation Oncology, Biology, Physics·James M GalvinUNKNOWN American Association of Physicists in Medicine
Sep 29, 2004·Neurosurgery Clinics of North America·Marie D KlishDennis C Shrieve
Mar 13, 2014·Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)·M SkórskaK Adamska
Jan 15, 2014·Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznań and Polish Society of Radiation Oncology·Małgorzata Skórska, Tomasz Piotrowski
Mar 4, 2009·Linear Algebra and Its Applications·Philipp Süss, Karl-Heinz Küfer
Jan 25, 2000·Cancer Treatment Reviews·N S Russell, H Bartelink
Jul 8, 2000·The British Journal of Radiology·C NuttingS Webb
Feb 28, 2004·The British Journal of Radiology·H V JamesA J Poynter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.